Funding

Channel Medsystems raises $22M

81 Views

What does Channel Medsystems do?

Channel Medsystems, is the company which is engaged in developing proprietary cryo ablation delivery technologies. The company is focusses on the healthcare of women and addresses problems of heavy mestrual bleeding. It is the 5th spin out of incubator Thera Nova. This a venture backed company which was found to bring innovation in women’s healthcare delivery. The company develops treatment for meeting the uniques needs of female patients and the high standards that are provided by the healthcare professionals.

How much Channel Medsystems was funded?

Channel Medsystems has raised $22M in Series C funding on August 31, 2015 from Third Point Ventures (Lead) Partner: Jason Hong, Boston Scientific, Aperture Venture Partners, InCube Ventures, Scientific Health Development Partners and Longwood Founders Fund

Previous funding

  • $9.8M in Series B funding on May 2, 2013 from Boston Scientific (Lead), InCube Ventures and Aperture Venture Partners
  • $6M in Debt Financing on October 15, 2014

What is next for Channel Medsystems?

As part of the funding, Jason Hong, Ph.D, of Third Point Ventures will join the Board of Directors of the company. The company will use the latest funding raised for initiating the pivotal study of its cryothermic technology and move a step closer to the commercialization of its endometrial ablation procedure which is the first of its kind, office based procedure.

More about Channel Medsystems

The company was founded in 2009 by Daniel R. Burnett. It has its headquarters in San Francisco, CA. The company’s unique solution for the heavy menstrual bleeding allows women to receive treatment in the comforts of the office of their gynecologist rather than a surgery department.

The company ensures that the patients have access to high quality outcomes which are delivered at the comforts of the office of the healthcare provider. The company’s novel cryothermic technology and strealined delivry system is developed from the feedback of the leading biomedical engineers and clinicans at the TheraNova, from which this company has spin out. The company’s first application focuses on the endometrial ablation for women who are suffering from heavy menstrual bleeding. Their cryometric technology is very versatile and has the potential for multiple applications in the future.

 

Related Posts